RICS Activators
RICS Activators are a specialized group of chemical compounds that play a pivotal role in modulating the activity of the RICS protein, a GTPase-activating protein associated with the regulation of cytoskeletal dynamics and cellular signaling pathways. These activators specifically enhance the function of RICS by various mechanisms, which may include allosteric modulation or direct binding to the regulatory regions of the protein, thus affecting its interaction with GTPases. The molecules in this class are designed to target the RICS protein's active sites or its interaction domains, which are crucial for its GTPase-activating functionality. By fine-tuning the activity of RICS, these activators can have profound effects on cell morphology, motility, and adhesion since RICS is integral to the remodeling of the actin cytoskeleton. Furthermore, these activators can influence signaling cascades that depend on RICS's regulation of small GTPases, implying that they have the potential to indirectly influence a variety of downstream cellular events that are vital for maintaining cellular homeostasis.
One of the key attributes of RICS Activators is their ability to selectively enhance RICS's interaction with specific GTPases without disrupting the general GTPase activity within the cell. This specificity is crucial for ensuring that the activators exert their effects primarily through the RICS protein, rather than generating widespread changes in cellular GTPase activity. The precise mechanisms by which these activators modulate RICS activity can vary; some may increase the affinity of RICS for its GTPase substrates, while others might stabilize the active conformation of RICS, promoting its activity. Through these specific interactions, RICS Activators are capable of influencing the signaling pathways that RICS regulates, thereby controlling processes such as synaptic plasticity, neuronal development, and the formation of dendritic spines. The action of these compounds is strictly at the molecular level, focusing on the biochemical interactions that lead to the functional enhancement of the RICS protein.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to an increase in intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate various targets, including those that could influence RICS signaling, enhancing its activity within the cell by promoting its interactions with its effectors. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that could prevent phosphorylation of proteins that compete with RICS for binding partners, thereby enhancing RICS activation and its downstream signaling effects. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which could enhance RICS function by modulating calcium-dependent signaling pathways that RICS is involved in. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which may lead to the phosphorylation of proteins that interact with RICS, potentially enhancing RICS’s activity in signaling pathways such as cytoskeletal organization. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that could shift cellular signaling balances, possibly freeing up pathway components that interact with RICS, thereby indirectly enhancing RICS signaling. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is involved in signaling pathways that regulate cytoskeletal rearrangements, which could indirectly enhance the activity of RICS by influencing its effector pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore, similar to Ionomycin, which can increase intracellular calcium and potentially enhance RICS activity through calcium-dependent signaling mechanisms. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Pertussis toxin inhibits Gi/o class of G-proteins, potentially freeing up G-protein coupled receptors to activate alternative pathways that may indirectly enhance the activity of RICS. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which may allow for increased activity of RICS by reducing the competitive inhibition on related signaling pathways that involve RICS. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
W-7 hydrochloride is a calmodulin antagonist; by influencing calmodulin-dependent pathways, it could indirectly enhance RICS activity via modulation of associated signaling pathways. | ||||||